Literature DB >> 31309878

Targeting Mitochondria through the Use of Mitocans as Emerging Anticancer Agents.

Ioana Macasoi1, Alexandra Mioc1, Marius Mioc1, Roxana Racoviceanu1, Irina Soica2, Adelina Chevereșan3, Cristina Dehelean1, Victor Dumitrașcu3.   

Abstract

Mitochondria are key players with a multi-functional role in many vital cellular processes, such as energy metabolism, redox regulation, calcium homeostasis, Reactive Oxygen Species (ROS) as well as in cell signaling, survival and apoptosis. These functions are mainly regulated through important enzyme signaling cascades, which if altered may influence the outcome of cell viability and apoptosis. Therefore some of the key enzymes that are vital for these signaling pathways are emerging as important targets for new anticancer agent development. Mitocans are compounds aimed at targeting mitochondria in cancer cells by altering mitochondrial functions thus causing cell growth inhibition or apoptosis. This review summarizes the till present known classes of mitocans, their mechanism of action and potential therapeutic use in different forms of cancer. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Bcl-2; Mithocondria; cancer; electron transport chain; hexokinase; lactate dehydrogenase; mitocans; pyruvate dehydrogenase kinase

Mesh:

Substances:

Year:  2020        PMID: 31309878     DOI: 10.2174/0929867326666190712150638

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  2 in total

1.  Feasibility and safety of targeting mitochondria for cancer therapy - preclinical characterization of gamitrinib, a first-in-class, mitochondriaL-targeted small molecule Hsp90 inhibitor.

Authors:  Umar Hayat; Gary T Elliott; Anthony J Olszanski; Dario C Altieri
Journal:  Cancer Biol Ther       Date:  2022-12-31       Impact factor: 4.875

2.  Rhodamine 101 Conjugates of Triterpenoic Amides Are of Comparable Cytotoxicity as Their Rhodamine B Analogs.

Authors:  Niels V Heise; Daniel Major; Sophie Hoenke; Marie Kozubek; Immo Serbian; René Csuk
Journal:  Molecules       Date:  2022-03-29       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.